ZombieHealthcare
What Happened to Calidi Biotherapeutics?
Ticker: CLDISPAC Year: 2021
Return
-97.1%
Current Price
$0.29
Peak Price
$1654.8
Trust Size
$14M
Summary
Calidi Biotherapeutics is a clinical-stage biotechnology company developing oncolytic virus-based immunotherapies for cancer treatment, delivered through proprietary stem cell platforms.
What Happened
Calidi Biotherapeutics went public through a SPAC merger and uses stem cells as delivery vehicles for cancer-killing viruses directly to tumors. The approach aims to overcome the immune system's tendency to neutralize viruses before they reach cancer cells. The stock has declined dramatically, with the company facing the cash-intensive challenges typical of early-stage oncology biotechs.
Timeline
2021-09-07
S-1 Registration Filed
Risk Indicators
⚠️ Reverse Split